These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Characteristics of vasopressin release during controlled reduction in arterial pressure. Wall BM; Runyan KR; Williams HH; Bobal MA; Crofton JT; Share L; Cooke CR J Lab Clin Med; 1994 Oct; 124(4):554-63. PubMed ID: 7930879 [TBL] [Abstract][Full Text] [Related]
3. [Hemodynamic effects of an inhibitor of the vascular effects of vasopressin in patients with congestive heart failure]. Nicod P; Goy J; Waeber B; Bussien JP; Turini GA; Nussberger J; Hofbauer KG; Brunner HR Schweiz Med Wochenschr; 1985 Dec; 115(50):1823-5. PubMed ID: 3841412 [TBL] [Abstract][Full Text] [Related]
4. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery. Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617 [TBL] [Abstract][Full Text] [Related]
5. Peripheral mechanisms involved in the pressor and bradycardic effects of centrally administered arachidonic acid. Aydin C; Yalcin M Prostaglandins Leukot Essent Fatty Acids; 2008 Jun; 78(6):361-8. PubMed ID: 18571395 [TBL] [Abstract][Full Text] [Related]
6. Effects of titrated arginine vasopressin on hemodynamic variables and oxygen transport in healthy and endotoxemic sheep. Westphal M; Stubbe H; Sielenkämper AW; Ball C; Van Aken H; Borgulya R; Bone HG Crit Care Med; 2003 May; 31(5):1502-8. PubMed ID: 12771625 [TBL] [Abstract][Full Text] [Related]
7. Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats. Maeda C; Schaan B; Oliveira E; Oliveira V; De Angelis K; Irigoyen M Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):574-80. PubMed ID: 17581211 [TBL] [Abstract][Full Text] [Related]
8. Cardiovascular effects associated with antidiuretic activity of vasopressin after blockade of its vasoconstrictor action in dehydrated dogs. Liard JF Circ Res; 1986 May; 58(5):631-40. PubMed ID: 3754791 [TBL] [Abstract][Full Text] [Related]
9. Safety and pharmacologic activity of a new nitrate ester, ITF 296, after intravenous administration in healthy volunteers. Sardina M; Love R; Mizrahi J; Monzani V; Bianchini C J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S72-9. PubMed ID: 8839230 [TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of centrally administered arachidonic acid in haemorrhage-induced hypotensive rats: investigation of a peripheral mechanism. Yalcin M; Aydin C Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):447-53. PubMed ID: 19702598 [TBL] [Abstract][Full Text] [Related]
11. Effect of hydration on plasma vasopressin, renin, and aldosterone responses to head-up tilt. Harrison MH; Geelen G; Keil LC; Wade CA; Hill LC; Kravik SE; Greenleaf JE Aviat Space Environ Med; 1986 May; 57(5):420-5. PubMed ID: 3518690 [TBL] [Abstract][Full Text] [Related]
12. Characterization of acute hemodynamic effects of antidiuretic agonists in conscious dogs. Liard JF J Cardiovasc Pharmacol; 1988 Feb; 11(2):174-80. PubMed ID: 2452311 [TBL] [Abstract][Full Text] [Related]
13. Influence of arginine vasopressin receptors and angiotensin receptor subtypes on the water intake and arterial blood pressure induced by vasopressin injected into the lateral septal area of the rat. Abrão Saad W; Antonio De Arruda Camargo L; Sérgio Cerri P; Simões S; Abrão Saad W; Garcia G; Izabel Gutierrez L; Guarda I; Saad Guarda R Auton Neurosci; 2004 Mar; 111(1):66-70. PubMed ID: 15109940 [TBL] [Abstract][Full Text] [Related]
14. Lack of effect of a selective vasopressin V1A receptor antagonist SR 49,059, on potentiation by vasopressin of adrenoceptor-mediated pressor responses in the rat mesenteric arterial bed. Heinemann A; Horina G; Stauber RE; Pertl C; Holzer P; Peskar BA Br J Pharmacol; 1998 Nov; 125(6):1120-7. PubMed ID: 9863637 [TBL] [Abstract][Full Text] [Related]
15. Impedance cardiography: a potential monitor for hemodialysis. Wynne JL; Ovadje LO; Akridge CM; Sheppard SW; Vogel RL; Van de Water JM J Surg Res; 2006 Jun; 133(1):55-60. PubMed ID: 16631198 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002). Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR; Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555 [TBL] [Abstract][Full Text] [Related]
17. [Hemodynamic changes in waking rats with acute streptozotocin diabetes after administration of the combined V2/V1 vasopressin antagonist]. Kuznetsova LV; Medvedeva NA; Medvedev OS Biull Eksp Biol Med; 1993 Jun; 115(6):594-6. PubMed ID: 8374133 [TBL] [Abstract][Full Text] [Related]
18. Vasopressin: a new target for the treatment of heart failure. Lee CR; Watkins ML; Patterson JH; Gattis W; O'connor CM; Gheorghiade M; Adams KF Am Heart J; 2003 Jul; 146(1):9-18. PubMed ID: 12851603 [TBL] [Abstract][Full Text] [Related]
19. DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin? Derkx FH; Man in 't Veld AJ; Jones R; Reid JL; Schalekamp MA J Hypertens Suppl; 1983 Dec; 1(2):58-61. PubMed ID: 6400119 [TBL] [Abstract][Full Text] [Related]
20. Arginine-vasopressin response to supine-erect posture change: an index for evaluation of the integrity of the afferent component of baroregulatory system in diabetic neuropathy. Cignarelli M; De Pergola G; Paternostro A; Corso M; Cospite MR; Centaro GM; Giorgino R Diabete Metab; 1986 Feb; 12(1):28-33. PubMed ID: 3699228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]